Fluticasone Propionate is a corticosteroid used to prevent and manage symptoms of asthma and chronic obstructive pulmonary disease (COPD). Asthma is a long-term condition where the airways become inflamed and produce excess mucus, leading to breathing difficulties. COPD refers to a group of lung diseases, including emphysema and chronic bronchitis, that cause airflow blockage and breathing issues.
Fluticasone Propionate works by reducing inflammation and calming the immune system in the lungs, which helps make breathing easier. This medication alleviates symptoms such as shortness of breath and wheezing.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Ticas 0.05% Cream (Fluticasone propionate) in its topical form is used to treat various inflammatory skin conditions, including dermatitis (skin irritation) and eczema (itchy, swollen skin). Ticas 0.05% Cream helps alleviate symptoms such as skin redness, blisters, soreness, and rashes. It works by preventing the release of certain chemicals in the body that cause inflammation, reducing swelling, redness, and pain associated with these skin conditions.
It is not known if alcohol affects Ticas 0.05% Cream. Please consult your doctor if you have any concerns.
The safety of Ticas 0.05% Cream in pregnant women is unknown. Therefore, it is given to pregnant women only if the doctor thinks the benefits outweigh the risks.
It is unknown whether Ticas 0.05% Cream is excreted in human milk. It is given to breastfeeding mothers only if the doctor thinks the benefits outweigh the risks.
Ticas 0.05% Cream usually does not affect your ability to drive or operate machinery.
Limited information is available. Please consult your doctor if you have any concerns. Your doctor will prescribe only if the benefits outweigh the risks.
Ticas 0.05% Cream should be taken cautiously in patients with hepatic disease.
Ticas 0.05% Cream (Fluticasone propionate) works by inhibiting certain cells causing redness and swelling (mast cells, neutrophils, lymphocytes, and macrophages) as well as by blocking the release of chemicals causing allergic reactions (histamine).
Ticas is used to relieve the symptoms of inflammation and itching associated with corticosteroid-responsive eczema or dermatitis.
Use as directed by a registered physician.
Fluticasone propionate is a glucocorticoid that has strong topical anti-inflammatory properties with minimal HPA-axis suppression when applied to the skin. Its therapeutic index is higher than that of most other available steroids. Fluticasone propionate binds selectively to glucocorticoid receptors, which are thought to mediate the anti-inflammatory effects of corticosteroids. Studies show that it has a strong affinity for glucocorticoid receptors, a weak affinity for progesterone receptors, and virtually no affinity for mineralocorticoid, estrogen, or androgen receptors. The duration of the therapeutic effect is linked to the half-life of the fluticasone-glucocorticoid receptor complex, which is around 10 hours.
Apply a thin layer to the affected area of the skin once daily.
Ticas may interact with anti-fungal (ketoconazole) and HIV medications (ritonavir). Inform your doctor if you are taking any other steroid medicines.
Inform your doctor if you have hyperadrenocorticism, infections, ocular herpes simplex, glaucoma, cataracts, bone problems, chickenpox, measles, or tuberculosis.
Fluticasone propionate should only be used during pregnancy if the potential benefit to the mother outweighs the possible risk to the fetus. It is unknown whether fluticasone is excreted in breast milk, but given the low likelihood of systemic absorption at recommended doses, the risks to a nursing infant are considered low. The potential benefits should be weighed against potential risks when used by breastfeeding mothers.
Although Ticas has a low risk of systemic absorption, prolonged use of large amounts over a large skin surface area—especially in infants and small children—could lead to adrenal suppression. Children are more susceptible to systemic toxicity because they absorb higher amounts of topical corticosteroids. Prolonged use on the face can cause skin thinning, so this should be taken into account when treating severe eczema. Infected inflammatory lesions require antimicrobial treatment, and corticosteroids should be discontinued if the infection spreads. Occlusive dressings may promote bacterial growth, so the skin should be cleansed before applying a fresh dressing.
Store below 30°C. Do not freeze. Keep out of reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.